Express News | Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone

BenzingaDec 12 09:02 ET

Exagen Inc. Achieves Key Milestone With 1,000,000th Patient Tested by AVISE CTD

GlobeNewswireDec 12 09:00 ET

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 15 15:55 ET

Exagen Inc. (NASDAQ:XGN) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall StNov 15 06:13 ET

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceNov 15 05:50 ET

Express News | Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the Avise® Ctd Platform

ReutersNov 14 16:30 ET